AFT Pharmaceuticals (JSE: AFT, ASX: ASX), a company based in New Zealand, has announced an agreement with Hainan Haiyao Co., Ltd (SZ:000566) to distribute AFT’s Crystaderm cream in China. The cream, a proprietary product of AFT, is designed to treat acne and skin infections through the slow release of hydrogen peroxide onto the skin, offering an alternative to topical antibiotics.
According to AFT’s announcement, the product is expected to launch in China before the end of this year, with Haiyao taking on the commercialization efforts. Further details of the deal were not disclosed.- Flcube.com
